Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/21645515.2020.1829413 http://scihub22266oqcxt.onion/10.1080/21645515.2020.1829413 33180669!8115564!33180669     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Hum+Vaccin+Immunother 2021 ; 17 (6): 1664-1665 Nephropedia Template TP {{tp|p=33180669|t=2021. Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?|pdf=|usr=}}{{33180669}} gab.com Text Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave JO: Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=33180669 #FOAvip We have checked the vaccination history of 389 elderly patients (62.9% males, mean age of 78.5 + 8.4 years) hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Information regarding pneumococcal vaccination was available for 354 patients (91.0%): the overall vaccination coverage rate (VCR) was 19.8% (70/354), 11.3% received only 13-valent pneumococcal conjugate vaccine (PCV13), 3.4% were immunized with 23-valent pneumococcal polysaccharide vaccine (PPSV23), 5.1% received both vaccines. VCR among the elderly population in Liguria Region was 26.2% (118,581/453,082), among them 13.7% received PCV13, 12.4% were immunized with at least one dose of PPSV23. Regarding the 2019-2020 influenza season vaccination data were available for 46 patients: 59% of them were immunized. VCR in the elderly population was 51.7% (234,153/453,082). Twit Text FOAVip Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave ????Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=33180669 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33180669 #FOAvip English Wikipedia <ref>{{Cite pmid|33180669}}</ref> Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave? #MMPMID33180669 Sticchi L; Taramasso L; Di Biagio A; Olobardi D; Icardi G; Bassetti M Hum Vaccin Immunother 2021[Jun]; 17 (6): 1664-1665 PMID33180669show ga We have checked the vaccination history of 389 elderly patients (62.9% males, mean age of 78.5 + 8.4 years) hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Information regarding pneumococcal vaccination was available for 354 patients (91.0%): the overall vaccination coverage rate (VCR) was 19.8% (70/354), 11.3% received only 13-valent pneumococcal conjugate vaccine (PCV13), 3.4% were immunized with 23-valent pneumococcal polysaccharide vaccine (PPSV23), 5.1% received both vaccines. VCR among the elderly population in Liguria Region was 26.2% (118,581/453,082), among them 13.7% received PCV13, 12.4% were immunized with at least one dose of PPSV23. Regarding the 2019-2020 influenza season vaccination data were available for 46 patients: 59% of them were immunized. VCR in the elderly population was 51.7% (234,153/453,082). |*COVID-19[MESH] |*Influenza, Human/epidemiology/prevention & control[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Antibodies, Bacterial[MESH] |Double-Blind Method[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Pandemics[MESH] |Pneumococcal Vaccines[MESH] |SARS-CoV-2[MESH] |Seasons[MESH] |Streptococcus pneumoniae/immunology[MESH] |Vaccination[MESH]Will vaccine hesitancy compromise our efforts to face the next SARS-Co(epmc).pdf DeepDyve Pubget Overpricing